SR-9011 Solution, 600MG (20mg/mL)SR 9011 SR 9011 is a research drug developed by Professor Thomas Burris at the Scripps Research Institute. It acts as an agonist for Rev ErbA with a half maximal inhibitory concentration (IC50) of 790 nM for Rev Erb and an IC50 of 560 nM for Rev ErbA. This drug is primarily used in studies exploring the regulation of circadian rhythms and its potential implications for the immune system, inflammation, and cancer. SR 9011 belongs to the second

it exhibits endo-exo isomerism

were purchased from Harlan for experimental testing

Evidence suggests that OTR-AC can help lower cholesterol levels

DISCLAIMERThis product is sold exclusively for laboratory research purposes and is not intended for human consumption

ACP-105 study

Cardarine (GW501516) – Powder

317318-70-0

Requirements

Ensure the container is tightly sealed to prevent degradation

IBUTAMOREN (MK-677) Solution

Studies suggest that OTR-AC can help stimulate bone formation and protect against bone disorders:

as a form of hormonal contraception for men